Favorable outcome of low-dose cyclosporine after pulse methylprenisolone in Japanese adult minimal-change nephrotic syndrome

Internal Medicine

Volumn 43, Issue 8, 2004, Pages 668-673

  Matsumoto, Hiroshi ^a   Nakao, Toshiyuki ^a   Okada, Tomanari ^a   Nagaoka, Yume ^a   Takeguchi, Fumihiro ^a   Tomaru, Ryo ^a   Iwasawa, Hideaki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Intravenous methylprednisolone pulse therapy; Minimal change nephrotic syndrome; Monotherapy; Prednisolone

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISOLONE;

ACNE; ADULT; AGED; ARTERY DISEASE; ARTICLE; ASEPTIC NECROSIS; ATROPHY; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PULSE THERAPY; FACE DISORDER; FEMALE; GINGIVA HYPERPLASIA; GLOMERULOPATHY; HAIR LOSS; HIRSUTISM; HUMAN; HYPERTENSION; JAPAN; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; LOW DRUG DOSE; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; OBESITY; PROSPECTIVE STUDY; RECURRENCE RISK; REMISSION; STATISTICAL SIGNIFICANCE; STOMACH HEMORRHAGE; STOMACH ULCER; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; METHYLPREDNISOLONE; NEPHROSIS, LIPOID; PROSPECTIVE STUDIES; PULSE THERAPY, DRUG; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 4644283933     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.668     Document Type: Article

References (18)

1. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams's DG. Adult-onset minimal change nephrotic syndrome: A long-term follow-up. Kidney Int 29: 1215-1223, 1986.
2. Imbasciati E, Gusmano R, Edefonti A, et al. Controlled trial of methypredisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J 291: 1305-1308, 1985.
3. Yorgin PD, Krasher J, Al-Uzri AY. Pulse methyprednisolone treatment of idiopathic steroid-resistant nephritic syndrome. Pediatr Nephrol 16: 245-250, 2001.
4. Matsumoto H, Nakao T, Okada Y, et al. Initial remission-inducing effect of very-low dose cyclosporine monotherapy for minimal-change nephrotic syndrome in Japanese adults. Clin Nephrol 55: 143-148, 2001.
5. Feutren G, Mihatsch ML for the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Disease. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326: 1654 1660, 1992.
6. Meyrier A, Noel LH, Auriche P, Collard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int 45: 1446-1456, 1994.
7. Ponticelli C, Rizzoni G, Edefonti A, et al. A randomized trial of cyclosporin in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43: 1377-1384, 1993.
8. Yeung CK, Wong KL, Ng WL. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome. Aust NZ J Med 13: 349-351, 1983.
9. Lindholm A, Welsh M, Alton C, Kahan BD. Demographic factors influencing cyclosporin pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability. Clin Pharmacol Ther 52: 359-371, 1992.
10. Ingulli E, Tejani A. Severe hypercholesterolemia inhibits cyclosporine A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol 3: 254-259, 1992.
11. Korbet SM, Schwartz MM, Lewis EJ. Minimal-change glomerulopathy of adulthood Am J Nephrol 8: 291-297, 1998.
12. Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephritic syndrome in adult: Response to corticosteroid therapy and frequency of relapse. Am J kidney Dis 17: 687-692, 1991.
13. Maher ER, Sweny P, Chappel M, Varghese Z, Moorhead JF. Cyclosporin in the treatment of steroid-responseive and steroid-resistant nephritic syndromein adults. Nephrol Dial Transplant 3: 728-732, 1988.
14. Brandis M, Burghard R, Leititis J, Zimmerhackl B, Hidebrandt F, Helmchen U. Cyclosporin A for treatment of nephrotic syndrome. Transplant Pro 20: S275-S279, 1988.
15. Meyrier A, Simon P, Perret G, Condamin-Meyrier MC. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. Br Med J 292: 789-792, 1986.
16. Niaudet P, Boeyer M, Habib R. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 151: S31-S36, 1991.
17. Melocoton TL, Kamil ES, Cohen AH, Fine RN. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 18: 583-588, 1991.
18. Hamahira K, Iijima K, Tanaka R, Nakamura H, Yoshikawa N. Recovery from cyclosporine-associated arteriopathy in childhood nephrotic syndrome. Pediatr Nephrol 16: 723-727, 2001.